Earnings Summary

Bristol-myers Squibb Co.’s revenue jumped 0.62% since last year same period to $11477Mn in the Q4 2023. On a quarterly growth basis, Bristol-myers Squibb Co. has generated 4.66% jump in its revenue since last 3-months.

Bristol-myers Squibb Co.’s net profit fell -12.86% since last year same period to $1762Mn in the Q4 2023. On a quarterly growth basis, Bristol-myers Squibb Co. has generated -8.61% fall in its net profits since last 3-months.

Bristol-myers Squibb Co.’s net profit margin fell -13.4% since last year same period to 15.35% in the Q4 2023. On a quarterly growth basis, Bristol-myers Squibb Co. has generated -12.68% fall in its net profit margins since last 3-months.

Bristol-myers Squibb Co.’s price-to-earnings ratio after this Q4 2023 earnings stands at 12.5.

Bristol-myers Squibb Co.’s earning per share (EPS) estimates for the current quarter stand at -4.11 - a -368.63% fall from last quarter’s estimates.

Bristol-myers Squibb Co.’s earning per share (EPS) estimates for the current year stand at -4.11.

Bristol-myers Squibb Co.’s earning per share (EPS) fell -6.59% since last year same period to 1.7 in the Q4 2023. This indicates that the Bristol-myers Squibb Co. has generated -6.59% annual rate of fall in its earning per share (EPS) in the last 4 quarters.

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Bristol-myers Squibb Co.’s return on assets (ROA) stands at 0.06.

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Bristol-myers Squibb Co.’s return on equity (ROE) stands at 0.27.

Bristol-myers Squibb Co. declared 0.57 dividend per share during the earnings announcement for Q4 2023.